Trials / Unknown
UnknownNCT03162809
Needle-Free Monitoring for IVF Patient Cycles
Venopuncture-Free Monitoring During IVF: Are More Frequent Sequential Salivary Hormone Measurements More Informative Than Daily Serum Monitoring of IVF Patients?
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (estimated)
- Sponsor
- Boston IVF · Academic / Other
- Sex
- Female
- Age
- 25 Years – 43 Years
- Healthy volunteers
- Accepted
Summary
Salivary diagnostic testing is emerging as a less invasive, inexpensive alternative to serum analyte measurements with proven diagnostic accuracy in clinical settings. This study aims to continue analyzing aspects of the performance of salivary hormone competitive immunoassays for monitoring patient's reproductive hormone profiles in the reproductive cycle. Hormone levels will be monitored during treatment cycles for infertility.
Detailed description
This study will be a prospective study to measure salivary and serum estrogen and progesterone levels in subject's voluntarily undergoing monitored infertility treatment cycles including controlled ovarian stimulation (COS) with oral agents or gonadotropins and controlled ovarian hyperstimulation (COH) for in vitro fertilization (IVF). Ultimately, the potential applicability and reliability of salivary steroid monitoring in IVF cycles will be assessed.
Conditions
Timeline
- Start date
- 2017-05-09
- Primary completion
- 2021-04-01
- Completion
- 2021-06-01
- First posted
- 2017-05-22
- Last updated
- 2020-08-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03162809. Inclusion in this directory is not an endorsement.